{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 AST - ST Cefotaxime"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K121863",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063597"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "June 25, 2012",
    "Summary Letter Received Date": "July 13, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Cefotaxime"
    ],
    "Specimen Type(s)": [
        "Isolated colonies"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2 System",
        "VITEK\u00ae 2 Compact System"
    ],
    "Method(s)/Technology(ies)": [
        "Automated growth-based detection",
        "Optical transmittance measurement"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Minimum inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK\u00ae 2 AST - ST Cefotaxime card for automated antimicrobial susceptibility testing of Streptococcus species",
    "Indications for Use Summary": "Designed for antimicrobial susceptibility testing of Streptococcus species using VITEK\u00ae 2 and VITEK\u00ae 2 Compact Systems to aid in the determination of in vitro susceptibility to cefotaxime.",
    "fda_folder": "Microbiology"
}